A.R.T. Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,700
Closed -$609K 302
2019
Q4
$609K Buy
+5,700
New +$594K 0.03% 759
2019
Q3
Sell
-12,800
Closed -$1.3M 1493
2019
Q2
$1.3M Buy
+12,800
New +$1.23M 0.07% 366
2018
Q4
Sell
-15,700
Closed -$1.69M 1391
2018
Q3
$1.69M Buy
15,700
+4,600
+41% +$505K 0.08% 347
2018
Q2
$1.22M Sell
11,100
-10,200
-48% -$1.06M 0.05% 544
2018
Q1
$2.14M Buy
21,300
+2,900
+16% +$297K 0.09% 356
2017
Q4
$1.81M Buy
+18,400
New +$1.74M 0.08% 400
2017
Q3
Sell
-14,500
Closed -$1.61M 1408
2017
Q2
$1.61M Sell
14,500
-700
-5% -$74K 0.09% 334
2017
Q1
$1.49M Sell
15,200
-4,300
-22% -$410K 0.07% 409
2016
Q4
$1.79M Buy
+19,500
New +$1.68M 0.11% 301
2016
Q2
Sell
-26,622
Closed -$1.9M 1413
2016
Q1
$1.9M Buy
26,622
+18,000
+209% +$1.21M 0.09% 347
2015
Q4
$613K Sell
8,622
-16,855
-66% -$1.13M 0.03% 770
2015
Q3
$1.57M Sell
25,477
-48,760
-66% -$3.41M 0.06% 465
2015
Q2
$5.38M Buy
+74,237
New +$5.48M 0.18% 139
2014
Q2
Sell
-11,374
Closed -$658K 1347
2014
Q1
$658K Sell
11,374
-111,239
-91% -$5.96M 0.03% 653
2013
Q4
$6.56M Buy
+122,613
New +$7.27M 0.35% 44

Other funds holding DGX

A.R.T. Advisors's DGX Position: Q1 2020 in Review

A.R.T. Advisors sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 5,700 shares — an estimated $609K sold.

A.R.T. Advisors first reported a position in DGX in Q4 2013 and held it in 15 quarters. The position peaked at $6.56M in Q4 2013. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • A.R.T. Advisors reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 5,700 Quest Diagnostics shares in Q1 2020, an estimated $609K.
  • A.R.T. Advisors first reported a position in Quest Diagnostics in Q4 2013 and held it in 15 quarters.
  • A.R.T. Advisors's Quest Diagnostics position peaked at $6.56M in Q4 2013.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.